Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Some people are microdosing certain weight loss drugs in an attempt to reap some of the drugs' benefits with fewer of their side effects. But doctors specializing in weight loss say that ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

Ozempic, approved for Type 2 diabetes, has gained fame for its weight-loss properties, especially among celebrities. Despite its rising popularity, ex ...

Let's take a detailed look at the dangers of using Ozempic: Reports link Ozempic to blindness and NAIOD, making it a risky ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...

ITV viewers slammed the show for 'sending a dangerous message' and 'medical misinformation' after a guest, showcased her before and after pictures.

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

As New Year's resolutions kick into high gear, weight loss ... names like Ozempic. It is no surprise, considering the millions of people worldwide struggling with obesity, PCOS and diabetes.

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...